These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 20723213)
1. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213 [TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954 [TBL] [Abstract][Full Text] [Related]
3. Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma. Chen CJ; Kyo S; Liu YC; Cheng YL; Hsieh CB; Chan DC; Yu JC; Harn HJ World J Gastroenterol; 2004 Mar; 10(5):638-42. PubMed ID: 14991929 [TBL] [Abstract][Full Text] [Related]
4. PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells. Toaldo C; Pizzimenti S; Cerbone A; Pettazzoni P; Menegatti E; Daniela B; Minelli R; Giglioni B; Dianzani MU; Ferretti C; Barrera G J Cell Mol Med; 2010 Jun; 14(6A):1347-57. PubMed ID: 19912441 [TBL] [Abstract][Full Text] [Related]
5. Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. Onishi T; Nouso K; Higashi T; Toshikuni N; Nakatsukasa H; Kobayashi Y; Uemura M; Yumoto E; Fujiwara K; Sato S; Nakamura S; Yokoyama J; Hanafusa T; Shiratori Y J Gastroenterol Hepatol; 2003 Oct; 18(10):1168-74. PubMed ID: 12974904 [TBL] [Abstract][Full Text] [Related]
6. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas. Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143 [TBL] [Abstract][Full Text] [Related]
8. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis. Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643 [TBL] [Abstract][Full Text] [Related]
9. Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer. Li W; Zeng J; Li Q; Zhao L; Liu T; Björkholm M; Jia J; Xu D Mol Cancer; 2010 May; 9():132. PubMed ID: 20509972 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT. Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630 [TBL] [Abstract][Full Text] [Related]
11. Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression. Li GQ; Guo WZ; Zhang Y; Seng JJ; Zhang HP; Ma XX; Zhang G; Li J; Yan B; Tang HW; Li SS; Wang LD; Zhang SJ Oncotarget; 2016 Jan; 7(3):2462-74. PubMed ID: 26575167 [TBL] [Abstract][Full Text] [Related]
12. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma. Nagao K; Tomimatsu M; Endo H; Hisatomi H; Hikiji K J Gastroenterol; 1999 Feb; 34(1):83-7. PubMed ID: 10204615 [TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis. Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581 [TBL] [Abstract][Full Text] [Related]
14. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells. Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871 [TBL] [Abstract][Full Text] [Related]
15. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells. Papanikolaou V; Iliopoulos D; Dimou I; Dubos S; Tsougos I; Theodorou K; Kitsiou-Tzeli S; Tsezou A Int J Oncol; 2009 Nov; 35(5):1141-9. PubMed ID: 19787269 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of hTERT promoter in hepatocellular carcinomas. Iliopoulos D; Satra M; Drakaki A; Poultsides GA; Tsezou A Int J Oncol; 2009 Feb; 34(2):391-9. PubMed ID: 19148473 [TBL] [Abstract][Full Text] [Related]
17. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485 [TBL] [Abstract][Full Text] [Related]
18. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression. Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381 [TBL] [Abstract][Full Text] [Related]
19. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells. Moon DO; Kim MO; Lee JD; Choi YH; Kim GY Cancer Lett; 2009 Dec; 286(2):172-9. PubMed ID: 19560862 [TBL] [Abstract][Full Text] [Related]
20. PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma. Zhou X; Zhu H; Lu J Pathol Res Pract; 2015 Apr; 211(4):316-9. PubMed ID: 25613699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]